Article info
PDFClinical and epidemiological research
Extended report
Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes
- Correspondence to Dr Anick Bérard, Research Center, CHU Sainte-Justine, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, QC H3T 1C5, Canada; anick.berard{at}umontreal.ca
Citation
Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes
Publication history
- Received July 14, 2017
- Revised October 10, 2017
- Accepted October 22, 2017
- First published December 8, 2017.
Online issue publication
October 31, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.